Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Dec 14;12 Suppl 14(Suppl 14):S5.
doi: 10.1186/1471-2105-12-S14-S5.

Integrative analysis workflow for the structural and functional classification of C-type lectins

Affiliations

Integrative analysis workflow for the structural and functional classification of C-type lectins

Geoffrey Koh et al. BMC Bioinformatics. .

Abstract

Background: It is important to understand the roles of C-type lectins in the immune system due to their ubiquity and diverse range of functions in animal cells. It has been observed that currently confirmed C-type lectins share a highly conserved domain known as the C-type carbohydrate recognition domain (CRD). Using the sequence profile of the CRD, an increasing number of putative C-type lectins have been identified. Hence, it is highly needed to develop a systematic framework that enables us to elucidate their carbohydrate (glycan) recognition function, and discover their physiological and pathological roles.

Results: Presented herein is an integrated workflow for characterizing the sequence and structural features of novel C-type lectins. Our workflow utilizes web-based queries and available software suites to annotate features that can be found on the C-type lectin, given its amino acid sequence. At the same time, it incorporates modeling and analysis of glycans - a major class of ligands that interact with C-type lectins. Thereafter, the results are analyzed together with context-specific knowledge to filter off unlikely predictions. This allows researchers to design their subsequent experiments to confirm the functions of the C-type lectins in a systematic manner.

Conclusions: The efficacy and usefulness of our proposed immunoinformatics workflow was demonstrated by applying our integrated workflow to a novel C-type lectin -CLEC17A - and we report some of its possible functions that warrants further validation through wet-lab experiments.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Analysis workflow. A schematic illustration of the integrated workflow. The left side of the panel summarizes the steps for the sequence and structural characterization of novel C-type lectins at various levels. The right side shows equivalent analyses for glycans that is needed in order to construct a virtual library amenable for virtual screening.
Figure 2
Figure 2
Construction of in silico library. The glycans from the array are listed out (in the modified condensed IUPAC format) and submitted to our glycan modeling server for generating conformers that are amenable for docking studies.
Figure 3
Figure 3
Features of CLEC17A. Summary of the relevant features found along the sequence of CLEC17A.
Figure 4
Figure 4
Predicted structure of CLEC17A. (A) Homology modeling of CLEC17A and the score of its structure calculated by Profiles-3D. (B) Ramachandran plot of the psi-phi angles between all amino acid residues of the predicted. Most of the residues fall within allowed regions (95.7%), a small percentage of residues are within the marginal regions (3.4%), and only 3 residues are located in the disallowed region (0.9%).
Figure 5
Figure 5
Virtual screening of CLEC17A against the in silico glycan library. (A) Binding sites on CLEC17A that were screened against the glycan library. (B) Structure of a glycan terminating with mannose bound to site 2 on CLEC17A. (C) Proportion of the glycans in the library terminating with the respective monosaccharides, and having plausible poses on binding sites 1 and 2.

References

    1. Weis WI, Taylor ME, Drickamer K. The C-type lectin superfamily in the immune system. Immunological Reviews. 1998;163:19–34. doi: 10.1111/j.1600-065X.1998.tb01185.x. - DOI - PubMed
    1. Tacken PJ, de Vries IJM, Torensma R, Figdor CG. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nature Reviews Immunology. 2007;7:790–802. doi: 10.1038/nri2173. - DOI - PubMed
    1. Hey T, Fiedler E, Rudolph R, Fiedler M. Artificial, non-antibody binding proteins for pharmaceutical and industrial applications. TRENDS in Biotechnology. 2005;23(10):514–522. doi: 10.1016/j.tibtech.2005.07.007. - DOI - PubMed
    1. Zelensky AN, Gready JE. The C-type lectin-like domain superfamily. FEBS Journal. 2005;272:6179–6217. doi: 10.1111/j.1742-4658.2005.05031.x. - DOI - PubMed
    1. van Kooyk Y, Rabinovich GA. Protein-glycan interactions in the control of innate and adaptive immune responses. Nature Immunology. 2008;9:593–601. - PubMed

Publication types

LinkOut - more resources